Associate Director of BiostatisticsTakeda Development Center Americas, Inc., Cambridge, MA, USACambridge, Massachusetts, United States
PB0632 - Quality of life outcomes following treatment with octocog alfa in patients with hemophilia A: 9-year interim read-out of the real-world AHEAD international study
Monday, June 26, 202318:30 – 19:30 ET
PB0636 - Clinical outcomes following treatment with octocog alfa in patients with severe hemophilia A and pre-existing target joints: 9-year interim read-out of the real-world AHEAD international study
PB0666 - Clinical outcomes following treatment with octocog alfa in patients with hemophilia A: 9-year interim read-out of the real-world AHEAD international study
PB1268 - Clinical Outcomes with Octocog Alfa in Patients with Hemophilia A in China: 1-year of Follow-up of the AHEAD International Study
Tuesday, June 27, 202318:30 – 19:30 ET
